Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients

Clinical trial NCT00241501 · COMPLETED

Trial details

NCT number: NCT00241501
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease (GERD)

Start date: 2004-02-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.